MedPath

Enalapril Maleate

Enalapril Maleate Tablets

Approved
Approval ID

505d5616-07bf-1e82-e054-00144ff8d46c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 12, 2021

Manufacturers
FDA

NuCare Pharmaceuticals, Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Enalapril Maleate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-3303
Application NumberNDA018998
Product Classification
M
Marketing Category
C73605
G
Generic Name
Enalapril Maleate
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 12, 2021
FDA Product Classification

INGREDIENTS (8)

LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
SODIUM STEARATEInactive
Code: QU7E2XA9TG
Classification: IACT
ENALAPRIL MALEATEActive
Quantity: 20 mg in 1 1
Code: 9O25354EPJ
Classification: ACTIB
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Enalapril Maleate - FDA Drug Approval Details